Bloomberg Daybreak: Europe Edition cover image

Tariff Plans Still In Limbo, Markets Hold Their Breath & Big Pharma Fears

Bloomberg Daybreak: Europe Edition

CHAPTER

Restructuring of a Health Agency: Implications for Drug Approvals

This chapter explores the major changes within a health agency, focusing on the dismissal of top officials and the layoff of around 10,000 employees. It emphasizes the potential impact on the pharmaceutical industry and raises concerns about the FDA's future role in drug approvals amid the restructuring.

00:00
Transcript
Play full episode

Remember Everything You Learn from Podcasts

Save insights instantly, chat with episodes, and build lasting knowledge - all powered by AI.
App store bannerPlay store banner